Metabolomics profiling in hypertension and blood pressure regulation: a review

키워드

참고문헌 (40)

1. Ahhmed AM, "A review of meat protein hydrolysates and hypertension", Meat Sci, 86(1), pp.110~118 (2010)
2. Tan JL, "StatPearls" (2019), StatPearls Publishing
3. Dietrich S, "Identification of serum metabolites associated with incident hypertension in the European prospective investigation into cancer and Nutrition-Potsdam study", Hypertension, 68(2), pp.471~477 (2016)
4. Aluko RE, "Food protein-derived renin-inhibitory peptides : in vitro and in vivo properties", J Food Biochem, 43(1), pp.e12648~ (2019)
5. Erdmann K, "The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease", J Nutr Biochem, 19(10), pp.643~654 (2008)
6. Sun Z, "Aging, arterial stiffness, and hypertension", Hypertension, 65(2), pp.252~256 (2015)
7. Akira K, "H-1 NMRbased metabonomic analysis of urine from young spontaneously hypertensive rats", J Pharmaceut Biomed, 46(3), pp.550~556 (2008)
8. Coutinho T, "Arterial stiffness is associated with increase in blood pressure over time in treated hypertensives", J Am Soc Hypertens, 8(6), pp.414~421 (2014)
9. Danaei G, "Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010 : a comparative risk assessment", Lancet Diabetes Endocrinol, 2, pp.634~647 (2014)
10. Krakoff LR, "2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations", J Am Coll Cardiol, 64(4), pp.394~402 (2014)
11. Lee SH, "A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats", Food Chem, 118(1), pp.96~102 (2010)
12. Navar-Boggan AM, "Proportion of US adults potentially affected by the 2014 hypertension guideline", Jama, 311(14), pp.1424~1429 (2014)
13. James PA, "2014evidence-based guideline for the management of high blood pressure in adults : report from the panel members appointed to the eighth Joint National Committee(JNC 8)", Jama, 311(5), pp.507~520 (2014)
14. Hao Y, "A nested case-control study of association between metabolome and hypertension risk", Biomed Res Int, 2016, pp.7646979~ (2016)
15. Hu C, "Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy", Mol BioSyst, 7(12), pp.3271~3279 (2011)
16. Li Y, "Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy", Evid-Based Complement Alternat Med, 2013, pp.625906~ (2013)
17. Zheng Y, "Metabolomics and incident hypertension among blacks : the atherosclerosis risk in communities study", Hypertension, 62(2), pp.398~403 (2013)
18. Ameta K, "Essential hypertension : a filtered serum based metabolomics study", Sci Rep, 7(1), pp.2153~ (2017)
19. Vermeirssen V, "Bioavailability of angiotensin I converting enzyme inhibitory peptides", Br J Nutr, 92(3), pp.357~366 (2004)
20. Aa JY, "Differential regulations of blood pressure and perturbed metabolism by total ginsenosides and conventional antihypertensive agents in spontaneously hypertensive rats", Acta Pharmacol Sin, 31(8), pp.930~937 (2010)
21. Brindle JT, "Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension", Analyst, 128(1), pp.32~36 (2003)
22. Lu Y, "Gas chromatography", time-of-flight mass spectrometry based metabonomic approach to differentiation hypertension-and age-related metabolic variation in spontaneously hypertensive rats, 2008, pp.22, 7~
23. Akira K, "A metabonomic study of biochemical changes characteristic of genetically hypertensive rats based on H-1 NMR spectroscopic urinalysis", Hypertens Res, 35(4), pp.404~412 (2012)
24. Akira K, "Metabonomic study on the biochemical response of spontaneously hypertensive rats to chronic taurine supplementation using H-1 NMR spectroscopic urinalysis", J Pharmaceut Biomed, 85, pp.155~161 (2013)
25. Bruce SJ, "Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography", mass spectrometry, 2009, pp.81(9), 3285~3296
26. Onuh JO, "A metabolomics approach for investigating urinary and plasma changes in spontaneously hypertensive rats(SHR)fed with chicken skin protein hydrolysates diets", J Funct Foods, 22, pp.20~33 (2016)
27. Onuh JO, "Metabolomics as a tool to study the mechanism of action of bioactive protein hydrolysates and peptides", Trends Food Sci Tech, 91, pp.9~ (2019)
28. Law WS, "Metabonomics investigation of human urine after ingestion of green tea with gas chromatography", mass spectrometry, liquid chromatography, Rapid Commun Mass Sp, pp.2008, 22(16)[DOI]
29. Wishart DS, "Metabolomics : applications to food science and nutrition research", Trends Food Sci Tech, 19(9), pp.482~493 (2008)
30. Llorach R, "An LCMS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption", J Proteome Res, 8(11), pp.5060~5068 (2009)
31. Hanifa MA, "Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5", 6 nephrectomy rat model, 2019, pp.15(8), 112~
32. Zhang ZH, "Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans", J Proteome Res, 15(10), pp.3802~3812 (2016)
33. James EL, "Serum metabolomics in animal models and human disease", Curr Opin Clin Nutr Metab Care, 18(5), pp.478~483 (2015)
34. Jiye A, "Global analysis of metabolites in rat and human urine based on gas chromatography", time-of-flight mass spectrometry, 2008, pp.379(1), 20~26
35. Lin YT, "Global plasma metabolomics to identify potential biomarkers of blood pressure progression", Arterioscler Thromb Vasc Biol, 40(8), pp.e227~e237 (2020)
36. van Deventer CA, "Use of metabolomics to elucidate the metabolic perturbation associated with hypertension in a black south African male cohort : the SABPA study", J Am Soc Hypertens, 92(2), pp.104~114 (2015)
37. Zhong L, "Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique", Eur Rev Med Pharmacol Sci, 18(23), pp.3673~3680 (2014)
38. Mellen PB, "Serum uric acid predicts incident hypertension in a biethnic cohort : the atherosclerosis risk in communities study", Hypertension, 48(6), pp.1037~1042 (2006)
39. Kulkarni H, "Plasma lipidomic profile signature of hypertension in Mexican American families : specific role of diacylglycerols", Hypertension, 62(3), pp.621~626 (2013)
40. Nikolic SB, "Metabolomics in hypertension", J Hypertens, 32(6), pp.1159~1169 (2014)

관련 논문AI추천